San Jose, CA, United States of America

Thao Perry

This inventor holds 47 USPTO granted patents and 3 published patent applications, plus 6 CIPO patents and 16 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Gilead Sciences, Inc., Cv Therapeutics, Inc., G.d. Searle & Company. Active years: 2002-2025.

USPTO Granted Patents = 47 

% Patents Active = 72.3

 

 

Average Co-Inventor Count = 10.7

ph-index = 12

Forward Citations = 475(Granted Patents)


Location History:

  • Chesterfield, MO (US) (2002 - 2006)
  • San Jose, CA (US) (2004 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Nucleoside Analogs
Adenosine Receptor Antagonists
Ion Channel Modulators
CaM Kinase Inhibitors
p38 Kinase Inhibitors
Substituted Pyrazoles
Therapeutic Applications
Fused Compounds
6-Azabenzimidazole
Eneoxindoles
AZAB Compounds
47 patents (USPTO):Explore Patents

Title: Thao Perry: A Trailblazer in Invention and Innovation

Introduction:

Thao Perry is a visionary inventor based in San Jose, CA, whose relentless passion for innovation has positioned him as a standout figure in the world of inventions. His dedication to creating impactful solutions sets him apart in the realm of patenting.

Latest Patents:

1. '1′-cyano nucleoside analogs and uses thereof': Thao Perry's patent unveils compounds and methods tailored for treating viral infections, either alone or combined with other agents, showcasing his commitment to advancing healthcare solutions.

2. 'Substituted 6-azabenzimidazole compounds': This patent demonstrates Perry's focus on developing treatments for diseases modifiable by hematopoietic progenitor kinase 1 (HPK1) inhibitors, such as HBV, HIV, and cancer.

Career Highlights:

With an impressive 37 patents to his name, Thao Perry has established himself as a prolific inventor contributing significantly to the fields of pharmaceuticals and healthcare. His innovative approach has led to groundbreaking solutions that address critical medical needs.

Collaborations:

Throughout his career, Perry has collaborated with esteemed companies such as Gilead Sciences, Inc. and CV Therapeutics, Inc., where he has worked alongside notable colleagues like Rao V Kalla and Jeff A Zablocki. These partnerships have allowed him to synergize expertise and drive innovation to new heights.

Conclusion:

In conclusion, Thao Perry's innovative spirit, coupled with his remarkable track record of patents and collaborations, underscores his pivotal role in shaping the landscape of inventions. His relentless pursuit of impactful solutions continues to inspire and set benchmarks for future inventors in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…